Clinical risk factors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer

Chun Ru Chien, Ya Chuan Hsu, Yao Ching Wang, Lai Lei Ting

Research output: Contribution to journalReview article

Abstract

Radiotherapy (RT) was an important tool in treating lung cancer. Radiation pneumonitits (RP) was one of the major side effects after thoracic RT. RP may further offset the potential survival benefit of concurrent chemoradiotherapy (CCRT). We reported our clinical results of 3D conformal radiotherapy (3DCRT) with focus on risk factors of RP. From Apr 2003 to Mar 2004, medical records of consecutive patients with lung cancer receiving thoracic RT with detailed lung dose data (V20 and mean lung dose (MLD)) and at least 3 months' follow up (FU) were reviewed and constituted the study group. Common toxicity criteria III were used for grading of RP. Univariate analysis by Fisher's exact test was used for analysis of risk factors . Thirty-five patients fulfilled our criteria. Most of them had stage III non-small cell lung cancer (NSCLC) (19/35) and received CCRT (18/35). The median RT dose was 54Gy. The median V20 and MLD were 22.7% and 14.3Gy. Grade II RP was noted in three patients only after median follow up of 6 months. Among patient, tumor, treatment, and RT related factors, MLD (≧ 16Gy) was found to be a significant risk factor (risk: 3/12 vs 0/23, p=0.03). V20(≧ 25%) and tumor location (middle/lower lobes) were also found to be risk factors with borderline statistical significance (p=0.056) MLD, V20 and the location of primary tumor were possible clinical predictors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer. Further work up was needed to clarify other possible risk factors.

Original languageEnglish
Pages (from-to)25-29
Number of pages5
JournalChinese Journal of Radiology
Volume30
Issue number1
Publication statusPublished - Feb 1 2005
Externally publishedYes

Fingerprint

Radiation Pneumonitis
Conformal Radiotherapy
Lung Neoplasms
Radiotherapy
Radiation
Lung
Chemoradiotherapy
Thorax
Mars
Neoplasms
Non-Small Cell Lung Carcinoma
Medical Records
Survival

Keywords

  • Lung neoplasms, therapeutic radiology
  • Radiation
  • Therapeutic radiology, complications
  • Therapeutic radiology, three-dimensional

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Clinical risk factors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer. / Chien, Chun Ru; Hsu, Ya Chuan; Wang, Yao Ching; Ting, Lai Lei.

In: Chinese Journal of Radiology, Vol. 30, No. 1, 01.02.2005, p. 25-29.

Research output: Contribution to journalReview article

Chien, Chun Ru ; Hsu, Ya Chuan ; Wang, Yao Ching ; Ting, Lai Lei. / Clinical risk factors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer. In: Chinese Journal of Radiology. 2005 ; Vol. 30, No. 1. pp. 25-29.
@article{10462e88b3b54032ae9c41728bdce2af,
title = "Clinical risk factors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer",
abstract = "Radiotherapy (RT) was an important tool in treating lung cancer. Radiation pneumonitits (RP) was one of the major side effects after thoracic RT. RP may further offset the potential survival benefit of concurrent chemoradiotherapy (CCRT). We reported our clinical results of 3D conformal radiotherapy (3DCRT) with focus on risk factors of RP. From Apr 2003 to Mar 2004, medical records of consecutive patients with lung cancer receiving thoracic RT with detailed lung dose data (V20 and mean lung dose (MLD)) and at least 3 months' follow up (FU) were reviewed and constituted the study group. Common toxicity criteria III were used for grading of RP. Univariate analysis by Fisher's exact test was used for analysis of risk factors . Thirty-five patients fulfilled our criteria. Most of them had stage III non-small cell lung cancer (NSCLC) (19/35) and received CCRT (18/35). The median RT dose was 54Gy. The median V20 and MLD were 22.7{\%} and 14.3Gy. Grade II RP was noted in three patients only after median follow up of 6 months. Among patient, tumor, treatment, and RT related factors, MLD (≧ 16Gy) was found to be a significant risk factor (risk: 3/12 vs 0/23, p=0.03). V20(≧ 25{\%}) and tumor location (middle/lower lobes) were also found to be risk factors with borderline statistical significance (p=0.056) MLD, V20 and the location of primary tumor were possible clinical predictors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer. Further work up was needed to clarify other possible risk factors.",
keywords = "Lung neoplasms, therapeutic radiology, Radiation, Therapeutic radiology, complications, Therapeutic radiology, three-dimensional",
author = "Chien, {Chun Ru} and Hsu, {Ya Chuan} and Wang, {Yao Ching} and Ting, {Lai Lei}",
year = "2005",
month = "2",
day = "1",
language = "English",
volume = "30",
pages = "25--29",
journal = "Chinese Journal of Radiology",
issn = "1018-8940",
publisher = "中華民國放射線醫學會",
number = "1",

}

TY - JOUR

T1 - Clinical risk factors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer

AU - Chien, Chun Ru

AU - Hsu, Ya Chuan

AU - Wang, Yao Ching

AU - Ting, Lai Lei

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Radiotherapy (RT) was an important tool in treating lung cancer. Radiation pneumonitits (RP) was one of the major side effects after thoracic RT. RP may further offset the potential survival benefit of concurrent chemoradiotherapy (CCRT). We reported our clinical results of 3D conformal radiotherapy (3DCRT) with focus on risk factors of RP. From Apr 2003 to Mar 2004, medical records of consecutive patients with lung cancer receiving thoracic RT with detailed lung dose data (V20 and mean lung dose (MLD)) and at least 3 months' follow up (FU) were reviewed and constituted the study group. Common toxicity criteria III were used for grading of RP. Univariate analysis by Fisher's exact test was used for analysis of risk factors . Thirty-five patients fulfilled our criteria. Most of them had stage III non-small cell lung cancer (NSCLC) (19/35) and received CCRT (18/35). The median RT dose was 54Gy. The median V20 and MLD were 22.7% and 14.3Gy. Grade II RP was noted in three patients only after median follow up of 6 months. Among patient, tumor, treatment, and RT related factors, MLD (≧ 16Gy) was found to be a significant risk factor (risk: 3/12 vs 0/23, p=0.03). V20(≧ 25%) and tumor location (middle/lower lobes) were also found to be risk factors with borderline statistical significance (p=0.056) MLD, V20 and the location of primary tumor were possible clinical predictors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer. Further work up was needed to clarify other possible risk factors.

AB - Radiotherapy (RT) was an important tool in treating lung cancer. Radiation pneumonitits (RP) was one of the major side effects after thoracic RT. RP may further offset the potential survival benefit of concurrent chemoradiotherapy (CCRT). We reported our clinical results of 3D conformal radiotherapy (3DCRT) with focus on risk factors of RP. From Apr 2003 to Mar 2004, medical records of consecutive patients with lung cancer receiving thoracic RT with detailed lung dose data (V20 and mean lung dose (MLD)) and at least 3 months' follow up (FU) were reviewed and constituted the study group. Common toxicity criteria III were used for grading of RP. Univariate analysis by Fisher's exact test was used for analysis of risk factors . Thirty-five patients fulfilled our criteria. Most of them had stage III non-small cell lung cancer (NSCLC) (19/35) and received CCRT (18/35). The median RT dose was 54Gy. The median V20 and MLD were 22.7% and 14.3Gy. Grade II RP was noted in three patients only after median follow up of 6 months. Among patient, tumor, treatment, and RT related factors, MLD (≧ 16Gy) was found to be a significant risk factor (risk: 3/12 vs 0/23, p=0.03). V20(≧ 25%) and tumor location (middle/lower lobes) were also found to be risk factors with borderline statistical significance (p=0.056) MLD, V20 and the location of primary tumor were possible clinical predictors of radiation pneumonitis after 3D conformal radiotherapy for lung cancer. Further work up was needed to clarify other possible risk factors.

KW - Lung neoplasms, therapeutic radiology

KW - Radiation

KW - Therapeutic radiology, complications

KW - Therapeutic radiology, three-dimensional

UR - http://www.scopus.com/inward/record.url?scp=18444363644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18444363644&partnerID=8YFLogxK

M3 - Review article

VL - 30

SP - 25

EP - 29

JO - Chinese Journal of Radiology

JF - Chinese Journal of Radiology

SN - 1018-8940

IS - 1

ER -